Research

1/6/20

A UB spinoff company that is developing a low-cost blood test to screen high-risk patients for unruptured brain aneurysms has received $750,000 Phase II Small Business Innovation Research (SBIR) funding from the National Science Foundation (NSF).

11/15/19

The University at Buffalo has officially launched the UB Biorepository, a critical new facility in the Clinical and Translational Research Center that will serve as a powerful resource in driving biomedical innovation in academia and industry regionally and throughout the state.

11/15/19

Sixty-seven oral and poster presentations were showcased at the 13th annual Neuroscience Research Day of the neuroscience program and the Buffalo Chapter of the Society for Neuroscience (SfN).

11/12/19

Atrophied brain lesion volume is the only marker from MRI scans that can accurately predict which patients will progress to the most severe form of multiple sclerosis (MS), according to a retrospective, five-year study of 1,314 MS patients.

9/17/19

Eighty-four student-scientists presented projects during the Ninth Annual Buffalo Summer Research Conference, an interdisciplinary forum marking the culmination of their summer research in Buffalo.

7/30/19

Department of Neurology researchers are helping to shed light on the effects of using gadodiamide as an imaging linear contrast agent in multiple sclerosis (MS) patients.

5/28/19

Students from laboratories affiliated with the Department of Biochemistry shared their findings during the department's annual Research Day.

5/22/19

Jessy J. Alexander, PhD, research professor of medicine in the Division of Nephrology, has received funding to study complement activation and its role in kidney disease.

5/7/19

The Hunter James Kelly Research Institute (HJKRI) has received more than $2 million in National Institutes of Health (NIH) funding, enabling researchers to pursue a new approach to Krabbe disease.